Posted On:
August 4, 2011
Drug Law News
- Jury selection began this week in a Nevada lawsuit filed against three companies that make or distribute pharmaceuticals by patients who allege they became infected with Hepatitis C through contaminated propofol during colonoscopies.
- Some lots of Vasopressin Injection are being recalled because they may not be as potent as intended.
- Some General Electric anesthesia breathing circuits are recalled because they may not allow enough oxygen to reach the patient.
- There have been major supply problems with Fabrazyme, the only drug approved for a rare genetic disease.
- Consumers file a class action over a GNC weight-loss drug. (Scroll down.)
- Who's to blame for faulty drugs?
- Should Pfizer be allowed to sell Lipitor over the counter?
- Johnson & Johnson is reducing its recommended maximum dosage to cut the risk of liver damage.>/li>
- High doses of Diflucan can lead to birth defects, the FDA says.
